GE HealthCare Technologies Cash on Hand 2020-2024 | GEHC
GE HealthCare Technologies cash on hand from 2020 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- GE HealthCare Technologies cash on hand for the quarter ending March 31, 2024 was $2.563B, a 10.14% increase year-over-year.
- GE HealthCare Technologies cash on hand for 2023 was $2.504B, a 73.29% increase from 2022.
- GE HealthCare Technologies cash on hand for 2022 was $1.445B, a 159.89% increase from 2021.
- GE HealthCare Technologies cash on hand for 2021 was $0.556B, a 44.79% decline from 2020.
| GE HealthCare Technologies Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $2,504 |
| 2022 | $1,445 |
| 2021 | $556 |
| 2020 | $1,007 |
| 2019 | $ |
| GE HealthCare Technologies Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-03-31 | $2,563 |
| 2023-12-31 | $2,504 |
| 2023-09-30 | $2,418 |
| 2023-06-30 | $1,939 |
| 2023-03-31 | $2,327 |
| 2022-12-31 | $1,445 |
| 2022-09-30 | $500 |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2020-12-31 | $1,007 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $35.257B | $19.552B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $5.669B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.401B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.980B | 0.00 |
| Axonics (AXNX) | United States | $3.445B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $3.202B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.010B | 0.00 |
| Azenta (AZTA) | United States | $2.800B | 157.42 |
| Enovis (ENOV) | United States | $2.438B | 18.07 |
| 10x Genomics (TXG) | United States | $2.234B | 0.00 |
| Privia Health (PRVA) | United States | $2.022B | 113.00 |
| Schrodinger (SDGR) | United States | $1.461B | 0.00 |
| Omnicell (OMCL) | United States | $1.229B | 42.48 |
| Phreesia (PHR) | United States | $1.177B | 0.00 |
| Standard BioTools (LAB) | United States | $0.682B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.621B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.596B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.365B | 0.00 |
| Talkspace (TALK) | United States | $0.365B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| Pulmonx (LUNG) | United States | $0.245B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.209B | 0.00 |
| Outset Medical (OM) | United States | $0.199B | 0.00 |
| TruBridge (TBRG) | United States | $0.168B | 9.02 |
| P3 Health Partners (PIII) | United States | $0.157B | 0.00 |
| American Well (AMWL) | United States | $0.089B | 0.00 |
| 111 (YI) | China | $0.088B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.080B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.071B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.049B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.048B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| CareCloud (CCLD) | United States | $0.032B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.031B | 0.00 |
| Movano (MOVE) | United States | $0.031B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Biotricity (BTCY) | United States | $0.007B | 0.00 |
| Transgenomic (PRPO) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |